Source: Letters in Drug Design & Discovery. Unidade: FCF
Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL
ABNT
FERNANDES, Thais Batista et al. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570180820666230131111033. Acesso em: 23 abr. 2024.APA
Fernandes, T. B., Yang, R., Ferreira, G. M., Souza, P. O. de, Lopes, V. G., Toledo, M. F. Z. J., et al. (2023). Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery. doi:10.2174/1570180820666230131111033NLM
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2023 ;[citado 2024 abr. 23 ] Available from: https://doi.org/10.2174/1570180820666230131111033Vancouver
Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2023 ;[citado 2024 abr. 23 ] Available from: https://doi.org/10.2174/1570180820666230131111033